HCT · ASX

Holista Colltech Limited (ASX:HCT)

AU$0.041

 -0.001 (-2.381%)
ASX:Live
01/05/2025 10:04:37 AM
Volume Spike HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

HCT Overview

HCT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About HCT

Website

N/A

Telephone

N/A

Address

Description

Holista CollTech Ltd. engages in the research and development, manufacture, and marketing of natural ingredients and wellness products. It operates through the following segments: Ovine Collagen, Infection Control, Dietary Supplements, and Food Ingredients. The company was founded by Rajen Manicka on September 18, 2000 and is headquartered in Perth, Australia.

HCT Price Chart

Key Stats

Market Cap

AU$12.29M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.04

Trade Value (12mth)

AU$882.00

1 week

-4.55%

1 month

35.48%

YTD

162.5%

1 year

320%

All time high

2.21

Key Fundamentals

EPS 3 yr Growth

-93.50%

EBITDA Margin

-15.50%

Operating Cashflow

-$1m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

-7.30

Quick Ratio

0.30

Other Data

Shares on Issue (Fully Dilluted)

279m

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

HCT Announcements

Latest Announcements

Date Announcements

30 April 25

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

30 April 25

Notification regarding unquoted securities - HCT

×

Notification regarding unquoted securities - HCT

29 April 25

Quarterly Activity and Cashflow Report

×

Quarterly Activity and Cashflow Report

28 April 25

Update - Notification regarding unquoted securities - HCT

×

Update - Notification regarding unquoted securities - HCT

24 April 25

Appointment of Chairperson

×

Appointment of Chairperson

17 April 25

Initial Director's Interest Notice

×

Initial Director's Interest Notice

17 April 25

Notification regarding unquoted securities - HCT

×

Notification regarding unquoted securities - HCT

16 April 25

Resignation of Non-Executive Directors

×

Resignation of Non-Executive Directors

01 April 25

Supreme Court Proceedings against ProImmune

×

Supreme Court Proceedings against ProImmune

01 April 25

Suspension from Quotation

×

Suspension from Quotation

01 April 25

Annual Report to shareholders

×

Annual Report to shareholders

01 April 25

Appendix 4G

×

Appendix 4G

01 April 25

Reinstatement to Quotation

×

Reinstatement to Quotation

26 March 25

Director Appointment

×

Director Appointment

12 March 25

Update - Proposed issue of securities - HCT

×

Update - Proposed issue of securities - HCT

12 March 25

Receipt of Converting Note Funds and Final ASIC Payment

×

Receipt of Converting Note Funds and Final ASIC Payment

10 March 25

Update on US Legal Matter

×

Update on US Legal Matter

06 March 25

Trading Halt

×

Trading Halt

06 March 25

Replacement Trading Halt

×

Replacement Trading Halt

28 February 25

Issue of Converting Notes

×

Issue of Converting Notes

28 February 25

Proposed issue of securities - HCT

×

Proposed issue of securities - HCT

28 February 25

Appendix 4E - Preliminary Final Report

×

Appendix 4E - Preliminary Final Report

29 January 25

Quarterly Activity and Cashflow Report

×

Quarterly Activity and Cashflow Report

23 January 25

Change in substantial holding

×

Change in substantial holding

03 January 25

Appointment of Executive Director and Interim CEO

×

Appointment of Executive Director and Interim CEO

HCT Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.02 -0.00 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.02 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -13.0 -230.8 98.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.01 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 42.2 -126.8 54.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock -14.8 -14.8 -28.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.01 -0.01 -0.01 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -32.1 -172.7 14.1 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 277 279 280 Lock Lock Lock
Basic m Lock Lock Lock Lock 277 279 280 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 8 6 6 Lock Lock Lock
     Growth % Lock Lock Lock Lock 2.7 -27.8 -5.9 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 2 3 1 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -22.5 -63.5 -76.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 12.3 6.2 1.6 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 88 94 98 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -1 -2 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.3 -92.8 60.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -13.9 -37.1 -15.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -1 -2 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -13.7 -72.5 60.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -17.2 -41.1 -17.3 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -1 -5 0 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -1 -5 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -15.7 -230.8 98.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -17.6 -80.8 -1.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -1 0 -1 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -1 0 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 30.7 65.4 -148.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.1 -0.1 -0.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 6 3 3 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 1 2 2 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 4 7 7 Lock Lock Lock
Equity $m Lock Lock Lock Lock 3 -2 -2 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 4 -1 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -23.4 -138.7 6.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -26.3 -141.5 -2.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -51.4 243.7 4.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -42.7 -510.3 0.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -35.7 -444.5 0.0 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -27.3 -37.7 0.0 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -17.2 -24.2 -7.3 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -1.0 -0.7 -2.0 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 39.0 -76.5 -100.8 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.4 0.4 0.4 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.9 0.3 0.3 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 2.9 2.6 0.8 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -38.6 -7.0 -16.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 5.1 4.7 4.9 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 4.9 5.4 7.5 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 7.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 13.7 54.8 37.2 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 1.5 1.8 1.6 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 1.5 1.8 1.6 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -16.6 -81.6 1.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -24.7 -142.9 2.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 223.6 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -26.3 -141.5 -2.5 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.9 -1.7 -2.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -51.4 243.7 4.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -51.4 243.7 4.9 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 74.1 67.7 48.6 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 71.6 77.6 74.4 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 145.7 145.4 123.1 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 64.1 143.5 172.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 81.6 1.9 -48.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

HCT Shortsell

Frequently Asked Questions

The current share price of Holista Colltech Limited (HCT:ASX) is AU$0.041.
The 52-week high share price for Holista Colltech Limited (HCT:ASX) is AU$0.04.
The 52-week low share price for Holista Colltech Limited (HCT:ASX)? is AU$0.00.
Holista Colltech Limited (HCT:ASX) does not pay a dividend.
Holista Colltech Limited (HCT:ASX) does not pay a dividend.
Holista Colltech Limited (HCT:ASX) has a franking level of 0.0%.
Holista Colltech Limited (HCT:ASX) is classified in the Healthcare.
The current P/E ratio for Holista Colltech Limited (HCT:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.